Skip to main content
VEEV logo

VEEV · Veeva Systems Inc

Track VEEV — free
$277.20 -11.21 (-3.89%) At close · Nov 18
Market Cap
$44.88B
Shares
161.91M
Volume · Nov 18 2.75M Avg daily vol (3M) 1.61M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$277.20 Open$287.67 Day$272.70–289.65 52W close$151.43–323.04 Avg vol 30d1.5M Short int3.9M · 2.4% of shares · 2.6d Short vol24% Last earningsAug 26, 2026 DataJan 2020–Nov 2026 Filing10-Q · Aug 27

Up next

Dec 3, 2026 Scheduled · in 2 wks

Latest documents

2026
Nov 6
Current report 8-K Events of Nov 5
Results expected to meet or exceed guidance

Veeva Systems Inc expects third quarter fiscal year 2027 results to meet or exceed guidance: total revenue $932-935 million, subscription revenue ~$782 million, services revenue $150-153 million, non-GAAP operating income $417-420 million, and non-GAAP fully diluted net income per share $2.33-2.34.

Financial results
3 source passages
Veeva Systems Inc. Total Revenue $932-935 million Subscription Revenue ~$782 million Services Revenue $150-153 million Non-GAAP Operating Income $417-420 million Non-GAAP Fully Diluted Net Income per Share $2.33-2.34 Expect to Meet or Exceed Q3’27 Guidance the Company expects to report third quarter of fiscal year 2027 results that meet or exceed the previously announced guidance Open the document at this passage
Aug 27
Quarterly report 10-Q FY2027 Q2, ended Jul 31
Quarterly report for FY2027 Q2 AI summary on its way
Revenue $927.96M ▲ 17.6% Net income $273.43M ▲ 36.5% Diluted EPS $1.66 ▲ 39.5%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.46B
Trailing 12 months
Net income (TTM)
$1.01B
Trailing 12 months
Revenue growth YoY
+17.6%
Year over year
Operating margin
29.9%
Trailing 12 months
P / E (TTM)
45.4
Trailing earnings · reciprocal yield 2.2%
FCF yield
—
TTM · current market cap
Return on invested capital
14.1%
Trailing 12 months
Net cash
$1.81B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.6%
Year over year · fewer shares
Price change (1Y)
+1.3%
Trailing year
Short interest
2.4%
Latest settlement · 2.6 days to cover
View all 125 metrics

AI Brief

Q2 FY27 earnings call · Aug 26, 2026
Q2 FY27

TL;DR. Q2 revenue and operating earnings grew, results exceeded guidance on all metrics, the full-year outlook improved, and CRM, Falcon, and R&D/Quality advanced. Risks include Falcon’s early readiness and regulatory hurdles, Aspen’s execution and revenue uncertainty, and long EDC implementations.

Bullish
  • + Q2 results exceeded guidance on all metrics and the full-year outlook improved across the board
  • + Total revenue rose 18% year over year to $928.0 million and subscription revenue rose 16% to $766.8 million
  • + GAAP operating income increased 40% and non-GAAP operating income increased 18% year over year
  • + Vault CRM expanded to more than 180 live customers and 12 top-20 commitments
  • + Falcon progressed with five early adopters and initial go-lives on track for this year
  • + R&D and Quality Cloud adoption broadened, with Safety exceeding 100 customers and Quality adding more than 30
Bearish
  • − Falcon readiness remains a constraint because the product must be prepared before engagement with early adopters
  • − Falcon remains too early to declare success and is a new market and motion for Veeva
  • − EDC has a long implementation cycle and some wins remain in the ramp-up phase
  • − Falcon must clear regulatory hurdles by demonstrating appropriate training and guardrails for human-in-the-loop agents
  • − Aspen execution remains uncertain because execution is the hard part in a startup
  • − Aspen revenue is not included in current plans

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Bullish Fundamentals Excellent Quant / Vol High
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +29%
above
Price vs 50-day avg −5%
below
RSI (14) 31
neutral
MACD trend Negative
52-week position 73%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −14%
trailing
6-month return +59%
trailing
YTD return +24%
this year
Relative strength +62%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $293 › 200d $215 — 50d above 200d
Institutional flow Accumulating
+13% holders QoQ · +253 funds added
Insider flow Distributing
Net -$1.5M over 90 days · 100% sells
Short interest Falling
2.39% of shares out · ▼ -8.1% MoM · 2.6 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
1,220 holders — near 3-yr high, broad support
Squeeze score 42
elevated · 0–100
Fundamentals
Excellent
Revenue growth +28%
Y/Y
Gross margin 219%
contracting
EPS growth +26%
Y/Y
Free cash flow $1.4B
Valuation P/E 45.4
rich
Buyback $1.4B
remaining
Balance sheet $1.4B
net cash
Quant / Vol
risk profile
High
Volatility 43%
annualized · 1-yr
Max drawdown −45%
past year
ATR 3.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 8 of last 8
Latest guidance · from the 8-K filed Aug 26, 2026
Total revenues · fiscal year ending January 31, 2027 Raised $3.68B – $3.69B
Jun 3, 2026 $3.64B – $3.65B changed to Aug 26, 2026 $3.68B – $3.69B
prior FY $3.2B midpoint +15.3% Y/Y
Non-GAAP operating income · fiscal year ending January 31, 2027 Non-GAAP Raised $1.64B
Jun 3, 2026 $1.61B changed to Aug 26, 2026 $1.64B
Non-GAAP fully diluted net income per share · fiscal year ending January 31, 2027 Non-GAAP Raised $9.21
Jun 3, 2026 $9.05 changed to Aug 26, 2026 $9.21
Previous outlook earlier release · from the Earnings Call filed Jun 3, 2026

Still-open targets the latest release did not restate under the same label.

Revenue · by 2030 $6B
Prior guidance period ended · from the 8-K filed Nov 6, 2026
Total Revenue · Q3’27 $932M – $935M
Subscription Revenue · Q3’27 $782M
Services Revenue · Q3’27 $150M – $153M
Non-GAAP Operating Income · Q3’27 $417M – $420M
Non-GAAP Fully Diluted Net Income per Share · Q3’27 $2.33 – $2.34
Guided vs delivered · last 8 settled
Total revenues fiscal second quarter ending July 31, 2026
guided $902M – $905M
$927.96M Beat +2.7%
Total revenues fiscal first quarter ending April 30, 2026
guided $855M – $858M
$882.95M Beat +3.1%
Total revenues fourth fiscal quarter ending January 31, 2026
guided $807M – $810M
$835.95M Beat +3.4%
Total revenues fiscal year ending January 31, 2026
guided $3.17B – $3.17B
$3.2B Beat +0.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+29% Bullish
Price vs 50-day avg
−5% Bearish
RSI (14)
31 Neutral
MACD trend
Negative Bearish
52-week position
73% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $293 › 200d $215 — 50d above 200d
Institutional flow Accumulating
+13% holders QoQ · +253 funds added
Insider flow Distributing
Net -$1.5M over 90 days · 100% sells
Short interest Falling
2.39% of shares out · ▼ -8.1% MoM · 2.6 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
1,220 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $151 Now $277 · 73% Range high $323
vs 200-day avg +29% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
GAAP → non-GAAP reconciliation
GAAP Diluted net income per share on a GAAP basis $1.66
+$0.83 Stock-based compensation expense
+$0.02 Amortization of purchased intangibles
+$0 Litigation settlement-related charges
-$0.16 Income tax effect on non-GAAP adjustments
= Diluted net income per share on a non-GAAP basis $2.35
GAAP → non-GAAP reconciliation
GAAP Net cash provided by operating activities on a GAAP basis 238.71M
-3.27M Excess tax (benefit) deficiency from employee stock plans
= Net cash provided by operating activities on a non-GAAP basis 235.44M
GAAP → non-GAAP reconciliation
GAAP Net income on a GAAP basis 273.43M
+136.8M Stock-based compensation expense
+4.06M Amortization of purchased intangibles
+0K Litigation settlement-related charges
-26.88M Income tax effect on non-GAAP adjustments
= Net income on a non-GAAP basis 387.41M
GAAP → non-GAAP reconciliation
GAAP Operating income on a GAAP basis 275.02M
+136.8M Stock-based compensation expense
+4.06M Amortization of purchased intangibles
+0K Litigation settlement-related charges
= Operating income on a non-GAAP basis 415.88M

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
VEEV
Veeva Systems Inc
this stock
$44.88B +24.2% +28.1% 45.4 2.4%
PMDIY
Pro Medicus Ltd.
$14.81B -14.6% — — 0.0%
BTSG
BrightSpring Health Services, Inc.
$13.60B +82.5% +28.2% 37.1 5.8%
TEM
Tempus AI, Inc.
$11.60B +7.7% +83.4% — 13.5%
HNGE
Hinge Health, Inc.
$9.31B +146.6% +50.6% 55.9 6.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1,220
% held
85.6%
Net QoQ
-6.4M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
857
View
Short & Settlement
Short Interest Falling
Shares short
3.9M
Days to cover
2.6d
Change
-339.5K sh
View
Short Volume
Short vol %
24%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
117
Value
$36.3K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
46.5%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$1.5M
Buyers / Sellers
0 / 2
Buyers Sellers
View
Congressional Trades Buy
Member
Rob Bresnahan
Amount
$1.0K–$15.0K
Traded
May 29, 2025
View
Financials
Financials
Revenue (FY)
$3.2B
Net income (FY)
$908.9M
EPS diluted
$5.44
View
Buybacks
Authorized
$2.0B
Remaining
$1.4B
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 6, 2026
This year
18

Veeva Systems Inc expects third quarter fiscal year 2027 results to meet or exceed guidance: total revenue $932-935 million, subscription revenue ~$782 million, services revenue $150-153 million, non-GAAP operating income $417-420 million, and non-GAAP fully diluted net income per share $2.33-2.34.

View
Proposed Sales
Value
$900.0K
Shares
3.0K
Filed
Oct 15, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 3, 2026
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Veeva to Release Fiscal 2027 Thir…
Published
Nov 12, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
VEEV -9.1% -13.5% +59.0% -11.4% +24.2%
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY -5.2% -8.0% +62.5% -8.1% +17.1%

Capital returns

Buyback program · as of Jul 31, 2026
Authorized
$2.00B
Spent (derived)
$600.00M
Remaining
$1.40B
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1393052 CUSIP 922475108 13F (30d) 1159 filings 1048 filers Visit website Investor relations